{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Matching+Placebo-Part+A&page=2", "query": { "intervention": "Matching Placebo-Part A", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Matching+Placebo-Part+A&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-23T18:16:40.127Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06964087", "title": "Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Type I Diabetes" ], "interventions": [ { "name": "OPT101", "type": "DRUG" }, { "name": "OPT101 Placebo to Match (PTM)", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Op-T LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 72, "start_date": "2026-04-10", "completion_date": "2028-08-19", "has_results": false, "last_update_posted_date": "2026-04-06", "last_synced_at": "2026-09-23T18:16:40.127Z", "location_count": 5, "location_summary": "Birmingham, Alabama • Walnut Creek, California • Aurora, Colorado + 2 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Renton", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT06964087" }, { "nct_id": "NCT03376321", "title": "A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Participants With Influenza A Infection", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Influenza A" ], "interventions": [ { "name": "Pimodivir 600 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "SOC Treatment", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "13 Years to 85 Years" }, "enrollment_count": 334, "start_date": "2018-01-03", "completion_date": "2020-04-30", "has_results": true, "last_update_posted_date": "2025-02-04", "last_synced_at": "2026-09-23T18:16:40.127Z", "location_count": 28, "location_summary": "Birmingham, Alabama • Jonesboro, Arkansas • Fresno, California + 23 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Fresno", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03376321" }, { "nct_id": "NCT06138795", "title": "A Single and Multiple Ascending Dose Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD2389 in Healthy Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Participants" ], "interventions": [ { "name": "AZD2389", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 120, "start_date": "2023-11-20", "completion_date": "2025-08-24", "has_results": false, "last_update_posted_date": "2025-09-09", "last_synced_at": "2026-09-23T18:16:40.127Z", "location_count": 1, "location_summary": "Glendale, California", "locations": [ { "city": "Glendale", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06138795" }, { "nct_id": "NCT04470427", "title": "A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "SARS-CoV-2" ], "interventions": [ { "name": "mRNA-1273", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "ModernaTX, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30415, "start_date": "2020-07-27", "completion_date": "2022-12-29", "has_results": true, "last_update_posted_date": "2024-03-21", "last_synced_at": "2026-09-23T18:16:40.127Z", "location_count": 100, "location_summary": "Birmingham, Alabama • Chandler, Arizona • Glendale, Arizona + 79 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT04470427" }, { "nct_id": "NCT00803686", "title": "A Study of Oral Calcitonin Given at Night to Healthy Postmenopausal Women", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Phase 1 Pharmacodynamic Study" ], "interventions": [ { "name": "Oral rsCT tablet", "type": "DRUG" }, { "name": "Oral Placebo Tablet", "type": "DRUG" }, { "name": "Fortical (rsCT) nasal spray", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Tarsa Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "45 Years", "maximum_age": "70 Years", "sex": "FEMALE", "summary": "45 Years to 70 Years · Female only" }, "enrollment_count": 12, "start_date": "2008-12", "completion_date": "2009-01", "has_results": true, "last_update_posted_date": "2014-06-09", "last_synced_at": "2026-09-23T18:16:40.127Z", "location_count": 1, "location_summary": "Springfield, Missouri", "locations": [ { "city": "Springfield", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00803686" }, { "nct_id": "NCT02919761", "title": "Safety and Effectiveness of Acthar Gel in Participants With Rheumatoid Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Arthritis, Rheumatoid" ], "interventions": [ { "name": "Acthar Gel", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mallinckrodt", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 259, "start_date": "2016-11-07", "completion_date": "2019-02-13", "has_results": true, "last_update_posted_date": "2020-03-31", "last_synced_at": "2026-09-23T18:16:40.127Z", "location_count": 30, "location_summary": "San Leandro, California • Upland, California • Boynton Beach, Florida + 23 more", "locations": [ { "city": "San Leandro", "state": "California" }, { "city": "Upland", "state": "California" }, { "city": "Boynton Beach", "state": "Florida" }, { "city": "Clearwater", "state": "Florida" }, { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02919761" }, { "nct_id": "NCT04723537", "title": "Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Covid19" ], "interventions": [ { "name": "Part A: Upamostat 200 mg", "type": "DRUG" }, { "name": "Part A: Upamostat 400 mg", "type": "DRUG" }, { "name": "Part A and B: Placebo", "type": "DRUG" }, { "name": "Part B: Upamostat 200 or 400 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "RedHill Biopharma Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 61, "start_date": "2021-02-16", "completion_date": "2021-12-28", "has_results": true, "last_update_posted_date": "2024-06-06", "last_synced_at": "2026-09-23T18:16:40.127Z", "location_count": 11, "location_summary": "Cutler Bay, Florida • Hialeah, Florida • Miami, Florida + 7 more", "locations": [ { "city": "Cutler Bay", "state": "Florida" }, { "city": "Hialeah", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Miami Springs", "state": "Florida" }, { "city": "Bay City", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT04723537" }, { "nct_id": "NCT07012395", "title": "A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Ulcerative Colitis", "Inflammatory Bowel Diseases", "Colitis", "Colitis, Ulcerative" ], "interventions": [ { "name": "SPY001", "type": "DRUG" }, { "name": "SPY002", "type": "DRUG" }, { "name": "SPY003", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Spyre Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 645, "start_date": "2025-05-27", "completion_date": "2028-03", "has_results": false, "last_update_posted_date": "2026-08-25", "last_synced_at": "2026-09-23T18:16:40.127Z", "location_count": 26, "location_summary": "Canoga Park, California • La Jolla, California • Lancaster, California + 23 more", "locations": [ { "city": "Canoga Park", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Lancaster", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Kissimmee", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07012395" }, { "nct_id": "NCT05614544", "title": "Dose-Finding and Human Abuse Potential Study Of HSK3486 Injection In Nondependent, Recreational Central Nervous System Depressant Users", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "General Anesthesia" ], "interventions": [ { "name": "HSK3486", "type": "DRUG" }, { "name": "Propofol", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Haisco-USA Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 42, "start_date": "2022-08-16", "completion_date": "2023-10-03", "has_results": false, "last_update_posted_date": "2023-10-13", "last_synced_at": "2026-09-23T18:16:40.127Z", "location_count": 1, "location_summary": "Salt Lake City, Utah", "locations": [ { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT05614544" }, { "nct_id": "NCT03305471", "title": "DS2330b Alone and With Sevelamer in Patients on Chronic Hemodialysis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hyperphosphatemia" ], "interventions": [ { "name": "DS-2330b PIB", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Sevelamer", "type": "DRUG" }, { "name": "DS-2330b Tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Daiichi Sankyo", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 40, "start_date": "2017-08-17", "completion_date": "2019-01-03", "has_results": false, "last_update_posted_date": "2019-03-25", "last_synced_at": "2026-09-23T18:16:40.127Z", "location_count": 4, "location_summary": "Lakewood, Colorado • Orlando, Florida • Minneapolis, Minnesota + 1 more", "locations": [ { "city": "Lakewood", "state": "Colorado" }, { "city": "Orlando", "state": "Florida" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Saint Paul", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT03305471" } ] }